Quarterly Results & Audited Results

Inter alia, to consider and approve:- 1. To consider and approve entering into an Agreement with Huwel Life Sciences Private Limited in relation to a proposed strategic investment to support growth and collaborative business opportunities, subject to necessary approvals. 2. To consider investment proposals and related matters. 3. Proposal to apply for name change of the Company. 4. To consider and approve incorporation of Wholly Owned Subsidiary and related matters. 5. Any other matter with the permission of the Chair.

Issue Of Warrants Inter alia: 1. To Consider, discuss and approve the aggregate funds to be raised by issue of warrants convertible into equity shares of the Company on preferential basis as may be permitted under applicable laws, and other incidental and ancillary matters in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018, to promoter / promoter group, subject to Shareholders? approval at ensuing Extraordinary General Meeting of the Company;

Inter alia, to consider and approve:- 1. the resolution passed by circulation dated 04.09.2025 2. To take a note of warning Letters received from BSE Limited 3. To authorise any Director of the Company for Dividend Account due for IEPF Transfer & Account Closure- Dutron Polymers Limited unpaid Dividend Account 17-18 4. To transact any other business with permission of chair.

Inter alia, to transact with or without modification the following transactions: 1. To consider and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement, private placement/ preferential issue of securities/Right issue or through any other permissible mode and/ or combination thereof as may be considered appropriate, subject to such regulatory approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such statutory / regulatory approvals, as applicable. 2. Any other business matter with the permission of Chair.

Inter alia, to consider and approve:- 1. Appointment of Independent Director. 2. Re-constitution of Committees

Inter alia, to consider and approve resignation of Mr. Ashwini Jha, Independent director

Inter alia, to consider and approve fund raising by way of issue of Secured Redeemable Non-Convertible Debentures on Private Placement basis

Quarterly Results

Inter alia, to consider the following:- 1. Acceptance the resignation letter received from Mr. Ummedmal Banthia (DIN 07314632) from Directorship of the Company on completion of his tenure on 27th September, 2025 as an Independent Director. 2. Re-structuring of Board, Audit Committee, Nomination & Remuneration Committee and Stakeholder Relationship Committee.